Logo

Biotique Licenses BLIS Informatics Platform to Bristol-Myers

Jul 09, 2002

NEW YORK, July 9 - Biotique Systems today said it has licensed its BLIS data-integration platform to Bristol-Myers Squibb.

 

The deal, sealed at the end of the last quarter, covers five BMS sites with some 2,000 employees, Biotique said. With the technology, BMS will be able to marry public genomic data with its in-house data.

 

Biotique, which counts as competitors Lion Bioscience and Compugen, has also licensed the BLIS platform to Berlex Biosciences.

 

Click here for more information.

Breaking News
The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.